FindTrial
Sign In

Risk of tuberculosis in Korean inflammatory bowel disease patients treated with Tumor Necrosis Factor-a (TNF-a) blockers

Risk of tuberculosis in inflammatory bowel disease patients treated with Tumor Necrosis Factor-a (TNF-a) blockers: A multicenter study in South Korea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001204
Enrollment
1000
Registered
2014-08-25
Start date
2014-07-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all IBD patients treated with TNF-a blockers at 8 academic referral hospitals in Korea

Exclusion criteria

Exclusion criteria: non-Koreans

Design outcomes

Primary

MeasureTime frame
Quantification of the incidence rate of TB in IBD patients treated with TNF-a blockers and compared that with general population rates—

Secondary

MeasureTime frame
clinical characteristics, including outcomes, and the risk factors of TB in IBD patients receiving TNF-a blocker therapy;aimed to investigate how latent TB screening is being carried out in actual clinical settings and its efficacy—

Countries

Korea, Republic of

Contacts

Public ContactJa Min Byun

Kyung Hee University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026